Advertisement
Organisation › Details
Enzyre B.V.
Enzyre is a spin-out from Radboud University Medical Center in The Netherlands founded by Waander van Heerde and Guido Maertens. The Company aims to develop a diagnostic device to provide patients with the flexibility to assess their coagulation status regardless of where they are. Enzyre’s platform requires a small volume of blood to measure up to sixteen reactions simultaneously with high sensitivity and specificity without any laboratory infrastructure, at home, on the road or in a critical care setting. This offers enormous benefits to patients: avoid crisis situations driven by changes in coagulation status, provide ease of mind for patients, empower patients to optimize treatment themselves, be a quick turnaround tool in the clinical setting, reduce GP consultation visits and, as a personalized diagnostic tool, offer great support in a telemedicine setting *
Start | 2016-01-01 established | |
Predecessor | Radboud University Medical Centre Nijmegen (RUMC) | |
Industry | point-of-care diagnostic device | |
Industry 2 | biochip product (array, bead, lab-on-a-chip) | |
Person | Pollet, Dirk (Enzyre 201904– CEO before Multiplicom + Cellectis + Galapagos + Innogenetics + Glaxo Wellcome) | |
Person 2 | Maertens, Guido (Enzyre 201904 CFO + Co-Founder) | |
Region | Nijmegen | |
Country | Netherlands | |
Street | 5 Transistorweg | |
City | 6534 AT Nijmegen | |
Tel | +31-24-6690036 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Enzyre B.V.. (11/2/22). "Press Release: Enzyre Closes Series A Financing Round of EUR 12M to Advance Pioneering Diagnostic Technology Platform for Hemophilia Patients". Nijmegen. | ||
Record changed: 2024-02-12 |
Advertisement
More documents for Enzyre B.V.
- [1] Enzyre B.V.. (11/2/22). "Press Release: Enzyre Closes Series A Financing Round of EUR 12M to Advance Pioneering Diagnostic Technology Platform for Hemophilia Patients". Nijmegen....
- [2] Enzyre B.V.. (4/30/19). "Press Release: Enzyre Appoints Dirk Pollet as Chief Executive Officer. Awarded €2M Grant and Completes Seed Financing". Nijmegen....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top